Biomarker-positive APOE4 Carriers with MCI Show Cognitive Stability over 4 Years of Oral Valiltramiprosate/ALZ-801 Treatment: MMSE Responder Analysis from the ALZ-801 Phase 2 Long-term Extension Study

valiltramiprosate (ALZ-801) - Alzheon

https://www.aan.com/msa/Public/Events/AbstractDetails/63353

James Kesslak1; Susan Abushakra1; Katrina Shearadova2; Jakub Hort3; Niels Prins4; Margaret Bray1; Adem Albayrak1; Aidan Power1; Martin Tolar1; John Hey1

Mar 6, 2026